Cited by 1,014Inflammasome and immune disordersImmune Response and InflammationUbiquitin and proteasome pathways

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome

Open access

Yan, Yiqing, Jiang, Wei, Liu, Lei, Wang, Xiaqiong, Ding, Chen, Tian, Zhigang, Zhou, Rongbin·2015·Cell

DOI 10.1016/j.cell.2014.11.047

Open this paper in CoChat — free account Open PDF

Abstract

Inflammasomes are involved in diverse inflammatory diseases, so the activation of inflammasomes needs to be tightly controlled to prevent excessive inflammation. However, the endogenous regulatory mechanisms of inflammasome activation are still unclear. Here, we report that the neurotransmitter dopamine (DA) inhibits NLRP3 inflammasome activation via dopamine D1 receptor (DRD1). DRD1 signaling negatively regulates NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP), which binds to NLRP3 and promotes its ubiquitination and degradation via the E3 ubiquitin ligase MARCH7. Importantly, in vivo data show that DA and DRD1 signaling prevent NLRP3 inflammasome-dependent inflammation, including neurotoxin-induced neuroinflammation, LPS-induced systemic inflammation, and monosodium urate crystal (MSU)-induced peritoneal inflammation. Taken together, our results reveal an endogenous mechanism of inflammasome regulation and suggest DRD1 as a potential target for the treatment of NLRP3 inflammasome-driven diseases.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2014.11.047

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Inflammasomes
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,401

Show all 49 references

Sorted by citations

Items 201–300 of 1,000

Inflammasome assembly in neurodegenerative diseases
Singh, J., Habean, M. L., & Panicker, N. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.009 · Cited by 83
Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance
Zhao, P., Yin, S., Qiu, Y., Sun, C., & Yu, H. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02217-2 · Cited by 102
Physiological concentrations of bilirubin control inflammatory response by inhibiting NF-κB and inflammasome activation
Li, Y., Huang, B., Ye, T., Wáng, Y., Xia, D., & Qian, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106520 · Cited by 84
Recent insights into the regulatory networks of NLRP3 inflammasome activation
Weber, A. N. R., Bittner, Z., Shankar, S., Liu, X., Chang, T.-H., Jin, T., & Tapia‐Abellán, A. (2020) · Journal of Cell Science · doi:10.1242/jcs.248344 · Cited by 85
GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages
Zhang, Q., Chen, L., Yang, H., Fang, Y., Wang, S., Wang, M., Yuan, Q., Wu, W. H., Zhang, Y., Liu, Z., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00825-y · Cited by 90
Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity
Bednash, J. S., Weathington, N. M., Londino, J. D., Rojas, M. M., Gulick, D. L., Fort, R., Han, S., McKelvey, A. C., Chen, B. B., & Mallampalli, R. K. (2017) · Nature Communications · doi:10.1038/ncomms15203 · Cited by 85
AKT Regulates NLRP3 Inflammasome Activation by Phosphorylating NLRP3 Serine 5
Zhao, W., Shi, C.-S., Harrison, K., Hwang, I., Nabar, N. R., Wang, M., & Kehrl, J. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000649 · Cited by 89
Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
Seok, J. K., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.618231 · Cited by 88
The Potential Therapeutic Role of miR-223 in Bovine Endometritis by Targeting the NLRP3 Inflammasome
Zhao, G., Jiang, K., Yang, Y., Zhang, T., Wu, H., Shaukat, A., Qiu, C., & Deng, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01916 · Cited by 83
LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis
Hu, J., Wu, H., Wang, D., Yang, Z., & Dong, J. (2018) · Biochimie · doi:10.1016/j.biochi.2018.10.011 · Cited by 81
Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome
Shim, D.-W., & Lee, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01054 · Cited by 80
Wedelolactone facilitates Ser/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis
Pan, H., Lin, Y., Dou, J., Fu, Z. F., Yao, Y., Ye, S., Zhang, S., Wang, N., Liu, A., Li, X., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12868 · Cited by 81
Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity
Contreras, F., Prado, C. E., González, H., Demane, D. F., Osorio‐Barrios, F., Osorio, F., Ugalde, V., López, E., Elgueta, D., Figueroa, A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502420 · Cited by 80
Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia
Cheng, J., Liao, Y., Xiao, L., Wu, R., Zhao, S., Chen, H., Hou, B., Zhang, X., Liang, C., Xu, Y., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.121 · Cited by 79
Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex–Mediated Activation of the NLRP3 Inflammasome
Shin, M. S., Kang, Y., Wahl, E. R., Park, H., Lazova, R. Z., Leng, L., Mamula, M. J., Krishnaswamy, S., Bucala, R., & Kang, I. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40672 · Cited by 79
Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson’s disease via promoting mitophagy
Hu, Z., Sun, T., Lu, M., Ding, J., Du, R., & Hu, G. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.009 · Cited by 82
Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma
Yan, Y., Pan, J., Chen, Y., Xing, W., Li, Q., Wang, D., Zhou, X., Xie, J., Miao, C., Yuan, Y., et al. (2020) · 癌症：英文版 · doi:10.1002/cac2.12103 · Cited by 79
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease
Huang, S., Chen, Z., Fan, B., Chen, Y., Zhou, L., Jiang, B., Long, H., Zhong, W., Li, X., & Li, Y. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577543 · Cited by 80
Kynurenic acid/GPR35 axis restricts NLRP3 inflammasome activation and exacerbates colitis in mice with social stress
Zheng, X., Hu, M., Zang, X., Fan, Q., Liu, Y., Che, Y., Guan, X., Hou, Y., Wang, G., & Hao, H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.009 · Cited by 79
Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation
Liu, Q., Su, L., Sun, C., Jiao, L., Miao, Y., Xu, M., Luo, R., Zuo, X., Zhou, R., Zheng, P., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101560 · Cited by 79
cAMP-PKA cascade: An outdated topic for depression?
Gao, F., Yang, S., Wang, J., & Zhu, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113030 · Cited by 83
Atp13a2 Deficiency Aggravates Astrocyte‐Mediated Neuroinflammation via NLRP 3 Inflammasome Activation
Qiao, C., Yin, N., Gu, H., Zhu, J., Ding, J., Lu, M., & Hu, G. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12514 · Cited by 77
Dopamine D2 receptor signalling controls inflammation in acute pancreatitis via a PP2A‐dependent Akt/NF‐κB signalling pathway
Han, X., Li, B., Ye, X., Mulatibieke, T., Wu, J., Dai, J., Wu, D., Ni, J., Zhang, R., Xue, J., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14057 · Cited by 79
Endoplasmic reticulum stress, an important factor in the development of Parkinson’s disease
Mou, Z., Yuan, Y., Zhang, Z., Song, L.-K., & Chen, N. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.01.019 · Cited by 77
Complementing the inflammasome
Triantafilou, M., Hughes, T. R., Morgan, B. P., & Triantafilou, K. (2016) · Immunology · doi:10.1111/imm.12556 · Cited by 76
Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice
Machado, V., Zöller, T., Attaai, A., & Spittau, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020151 · Cited by 76
NLRP3 Activation Was Regulated by DNA Methylation Modification during Mycobacterium tuberculosis Infection
Wei, M., Wang, L., Wu, T., Xi, J., Han, Y.-Z., Yang, X., Zhang, D., Fang, Q., & Tang, B. (2016) · BioMed Research International · doi:10.1155/2016/4323281 · Cited by 76
Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing
Tang, H., Zhao, X., & Jiang, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.001 · Cited by 80
Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation
Wan, P., Zhang, Q., Liu, W., Jia, Y., Ai, S., Wang, T., Wang, W., Pan, P., Yang, G., Xiang, Q., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801681r · Cited by 82
Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer’s Disease: a Review of Mechanism of Activation, Regulation, and Inhibition
Sharma, B., Satija, G., Madan, A., Garg, M., Alam, M. M., Shaquiquzzaman, M., Khanna, S., Tiwari, P., Parvez, S., Iqubal, A., et al. (2022) · Inflammation · doi:10.1007/s10753-022-01730-0 · Cited by 77
Targeting NLRP3 inflammasome for neurodegenerative disorders
Yao, J., Wang, Z., Song, W., & Zhang, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02239-0 · Cited by 81
The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice
Douglas, T., Champagne, C., Morizot, A., Lapointe, J., & Saleh, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500542 · Cited by 75
Association Between Interleukin-6 and Striatal Prediction-Error Signals Following Acute Stress in Healthy Female Participants
Treadway, M. T., Admon, R., Arulpragasam, A. R., Mehta, M., Douglas, S., Vitaliano, G. D., Olson, D. P., Cooper, J. A., & Pizzagalli, D. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1183 · Cited by 71
Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition
Baker, P. J., Nardo, D. D., Moghaddas, F., Tran, L. S., Bachem, A., Nguyen, T. A., Hayman, T. J., Tye, H., Vince, J. E., Bedoui, S., et al. (2017) · Physiological Reviews · doi:10.1152/physrev.00026.2016 · Cited by 75
Target acquired: Selective autophagy in cardiometabolic disease
Evans, T. D., Sergin, I., Zhang, X., & Razani, B. (2017) · Science Signaling · doi:10.1126/scisignal.aag2298 · Cited by 74
Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination
Chen, H., Lin, H. P., Xie, S., Huang, B., Qian, Y., Chen, K., Niu, Y., Shen, H., Cai, J., Li, P., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.019 · Cited by 75
Systematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD)
Sukmajaya, A. C., Lusida, M. I., Soetjipto, S., & Setiawati, Y. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00330-w · Cited by 79
Role of LRRK2 in the regulation of dopamine receptor trafficking
Rassu, M., Giudice, M. G. D., Sanna, S., Taymans, J., Morari, M., Brugnoli, A., Frassineti, M., Masala, A., Esposito, S., Galioto, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179082 · Cited by 81
Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra
Rodriguez-Perez, A. I., Garrido‐Gil, P., Pedrosa, M. A., García-Garrote, M., Valenzuela, R., Navarro, G., Franco, R., & Labandeira-García, J. L. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.011 · Cited by 73
Heat stress-induced intestinal barrier damage and dimethylglycine alleviates via improving the metabolism function of microbiota gut brain axis
Wang, Z., Shao, D., Wu, S., Song, Z., & Shi, S. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114053 · Cited by 76
Pyroptosis in development, inflammation and disease
Pan, Y., Cai, W., Huang, J., Cheng, A., Wang, M., Yin, Z., & Jia, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991044 · Cited by 74
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 76
Heat Shock Proteins and Inflammasomes
Martine, P., & Rébé, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184508 · Cited by 72
Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation
Xu, T., Yu, W., Fang, H., Wang, Z., Chi, Z., Guo, X., Jiang, D., Zhang, K., Chen, S., Li, M., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00947-8 · Cited by 73
GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis
Chen, T.-X., Meng, Y., Zhou, Z.-H., Li, H., Wan, L.-F., Kang, A., Guo, W., Ren, K., Song, X., Chen, Y., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01183-4 · Cited by 66
Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson’s disease
Pal, R., Tiwari, P. C., Nath, R., & Pant, K. K. (2016) · Neurological Research · doi:10.1080/01616412.2016.1249997 · Cited by 74
Regulation of the Mdm2–p53 pathway by the ubiquitin E3 ligase MARCH7
Zhao, K., Yang, Y., Zhang, G., Wang, C., Wang, D., Wu, M., & Mei, Y. (2018) · EMBO Reports · doi:10.15252/embr.201744465 · Cited by 70
Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway
Huang, B., Qian, Y., Xie, S., Ye, X., Chen, H., Chen, Z., Zhang, L., Xu, J., Hu, H., Ma, S., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0444-5 · Cited by 72
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Soraci, L., Gambuzza, M. E., Biscetti, L., Laganà, P., Russo, C. L., Buda, A., Barresi, G., Corsonello, A., Lattanzio, F., Lorello, G., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11491-3 · Cited by 76
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
Jiang, H., Gong, T., & Zhou, R. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.003 · Cited by 71
NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
Yan, Y., Fang, Y., Zheng, R., Pu, J., & Zhang, B. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.004 · Cited by 72
The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson’s Disease
Mackie, P. M., Lebowitz, J., Saadatpour, L., Nickoloff, E., Gaskill, P. J., & Khoshbouei, H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.020 · Cited by 75
Targeting the Dopaminergic System in Autoimmunity
Vidal, P. M., & Pacheco, R. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09834-5 · Cited by 71
Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson’s disease model
Gao, M.-R., Wang, M., Jia, Y., Tian, D., Liu, A., Wang, W.-J., Yang, L., Chen, J., Yang, Q., Liu, R., et al. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.015 · Cited by 69
The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation‐mediated metabolic diseases
Degechisa, S. T., Dabi, Y. T., & Gizaw, S. T. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.647 · Cited by 69
Signal-induced NLRP3 phase separation initiates inflammasome activation
Zou, G., Tang, Y., Yang, J., Fu, S., Li, Y., Ren, X., Zhou, N., Zhao, W., Gao, J., Ruan, Z., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01096-6 · Cited by 78
Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich–Containing Family, Pyrin Domain–Containing-3) Inflammasome in Cardiovascular Disorders
Wang, Z., Hu, W., Lu, C., Ma, Z., Jiang, S., Gu, C., Acuña-Castroviejo, D., & Yang, Y. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311916 · Cited by 72
Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 75
Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis
Cheng, Y., Pan, X., Wang, J., Li, X., Yang, S., Yin, R., Ma, A., & Zhu, X. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3186306 · Cited by 73
Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine
Yang, F., Chen, Z., Pathak, J. L., Carneiro, A. M. D., & Chung, C. Y. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00309 · Cited by 66
Zinc provides neuroprotection by regulating NLRP3 inflammasome through autophagy and ubiquitination in a spinal contusion injury model
Lin, J., Tian, H., Zhao, X., Lin, S., Li, D., Liu, Y., Xu, C., & Mei, X. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13460 · Cited by 68
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation
Xia, J., Jiang, S., Dong, S., Liao, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076126 · Cited by 74
Crosstalk Between the Neuroendocrine System and Bone Homeostasis
Zhao, Y., Peng, X., Wang, Q., Zhang, Z., Wang, L., Xu, Y., Yang, H., Bai, J., & Geng, D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad025 · Cited by 75
Innate recognition of microbial-derived signals in immunity and inflammation
Zhang, Y., & Liang, C. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0325-6 · Cited by 69
NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
Moltrasio, C., Romagnuolo, M., & Marzano, A. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007705 · Cited by 71
The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
Arioz, B. I., Tarakcioglu, E., Olcum, M., & Genç, Ş. (2021) · Antioxidants · doi:10.3390/antiox10071020 · Cited by 67
Post-translational control of NLRP3 inflammasome signaling
O'Keefe, M. E., Dubyak, G., & Abbott, D. W. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107386 · Cited by 68
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Pavillard, L. E., Marín‐Aguilar, F., Bullón, P., & Cordero, M. D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.018 · Cited by 67
Lycium barbarum glycopeptide alleviates neuroinflammation in spinal cord injury via modulating docosahexaenoic acid to inhibiting MAPKs/NF-kB and pyroptosis pathways
Jiang, Z.-F., Zeng, Z., He, H., Li, M., Lan, Y., Hui, J., Bie, P., Chen, Y., Liu, H., Fan, H., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04648-9 · Cited by 67
Asiatic Acid Protects Dopaminergic Neurons from Neuroinflammation by Suppressing Mitochondrial ROS Production
Chen, D., Zhang, X., Sun, J., Cong, Q., Chen, W.-X., Ahsan, H. M., Gao, J., & Qian, J.-J. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.188 · Cited by 66
The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era
Chilunda, V., Calderon, T. M., Martínez-Aguado, P., & Berman, J. W. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146426 · Cited by 66
Update of inflammasome activation in microglia/macrophage in aging and aging‐related disease
Hu, M., Lin, Y., Zhang, B., Lu, D., Lu, Z., & Cai, W. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13262 · Cited by 67
Pathophysiology linking depression and type 2 diabetes: Psychotherapy, physical exercise, and fecal microbiome transplantation as damage control
Subba, R., Sandhir, R., Singh, S. P., Mallick, B. N., & Mondal, A. C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15136 · Cited by 69
Stress and the “extended” autonomic system
Goldstein, D. S. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102889 · Cited by 76
Regulation of the NLRP3 Inflammasome by Posttranslational Modifications
Zangiabadi, S., & Sater, A. A. A. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100734 · Cited by 63
E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis
Shi, Y., Yang, Y., Xu, W., Shi, D., Xu, W., Fu, X., Lv, Q., Xia, J. L., & Shi, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04553-x · Cited by 65
Impact of Morphology on Iron Oxide Nanoparticles-Induced Inflammasome Activation in Macrophages
Liu, L., Sha, R., Yang, L., Zhao, X., Zhu, Y., Gao, J., Zhang, Y., & Wen, L. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17474 · Cited by 65
The Neurobiology of Motivational Deficits in Depression—An Update on Candidate Pathomechanisms
Treadway, M. T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_400 · Cited by 66
NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination
Park, H.-S., Liu, G., Raman, S. N. T., Landreth, S. L., Liu, Q., & Zhou, Y. (2018) · Journal of Virology · doi:10.1128/jvi.00022-18 · Cited by 68
Inhibition of NLRP3 Inflammasome Activation and Pyroptosis in Macrophages by Taraxasterol Is Associated With Its Regulation on mTOR Signaling
Yang, F., Ye, X.-J., Chen, M., Li, H., Wang, Y., Zhong, M.-Y., Zhong, C.-S., Zeng, B., Xu, L., He, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632606 · Cited by 64
A dopamine-precursor-based nanoprodrug for in-situ drug release and treatment of acute liver failure by inhibiting NLRP3 inflammasome and facilitating liver regeneration
Zhan, C., Lin, G., Huang, Y. X., Wang, Z., Zeng, F., & Wu, S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120573 · Cited by 63
Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes
Shirasuna, K., Karasawa, T., & Takahashi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27475 · Cited by 62
Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development
Zhou, L., Liu, T., Huang, B., Luo, M., Chen, Z., Zhao, Z., Wang, J., Leung, D., Yang, X., Chan, K. W., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.09.003 · Cited by 62
Role of Microgliosis and NLRP3 Inflammasome in Parkinson’s Disease Pathogenesis and Therapy
de Araújo, F. M., Cuenca‐Bermejo, L., Fernández‐Villalba, E., Costa, S. L., da Silva, V. D. A., & Herrero, M. T. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01027-6 · Cited by 63
Is acupuncture effective in the treatment of COVID-19 related symptoms? Based on bioinformatics/network topology strategy
Han, Z., Zhang, Y., Wang, P., Tang, Q., & Zhang, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab110 · Cited by 61
A dual-action strategy: Wound microenvironment responsive hydrogel and exosome-mediated glucose regulation enhance inside-out diabetic wound repair
Tang, S., Feng, K., Yang, R., Yang, C., Shi, N., Zhang, H., Zhao, W. H., & Ma, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113716 · Cited by 65
Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease
Elgueta, D., Aymerich, M. S., Contreras, F., Montoya, A., Celorrio, M., Rojo-Bustamante, E., Riquelme, E., González, H., Vásquez, M., Franco, R., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.028 · Cited by 61
GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics
Tang, T., Gong, T., Jiang, W., & Zhou, R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.002 · Cited by 64
Myeloid‐specific dopamine D2 receptor signalling controls inflammation in acute pancreatitis via inhibiting M1 macrophage
Han, X., Ni, J., Wu, Z., Wu, J., Li, B., Ye, X., Dai, J., Chen, C., Xue, J., Wan, R., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15026 · Cited by 61
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
Terkelsen, M. H., Klæstrup, I. H., Hvingelby, V. S., Lauritsen, J., Pavese, N., & Romero‐Ramos, M. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223245 · Cited by 64
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Chiarini, A., Gui, L., Viviani, C., Armato, U., & Prà, I. D. (2023) · Biomedicines · doi:10.3390/biomedicines11040999 · Cited by 62
Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
Baptista, A. F., Baltar, A., Okano, A. H., Moreira, A., Campos, A. C. P., Fernandes, A. M., Brunoni, A. R., Badran, B. W., Tanaka, C., de Andrade, D. C., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.573718 · Cited by 62
DA-DRD5 signaling controls colitis by regulating colonic M1/M2 macrophage polarization
Liu, L., Wu, Y., Wang, B., Jiang, Y., Lin, L., Li, X., & Yang, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03778-6 · Cited by 59
Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors
Kinra, M., Nampoothiri, M., Arora, D. S., & Mudgal, J. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13124 · Cited by 60
Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases
Brahadeeswaran, S., Sivagurunathan, N., & Latchoumycandane, C. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02683-5 · Cited by 63
Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease
Hulse, J. P., & Bhaskar, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805169 · Cited by 63
Platelet-rich plasma-derived exosomes attenuate intervertebral disc degeneration by promoting NLRP3 autophagic degradation in macrophages
Qian, J., Wang, X., Su, G., Shu, X., Huang, Z., Jiang, H., & Zhu, Q. A. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108962 · Cited by 61
β-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between β-arrestin2 and STAT3 in mouse model of depression
Liu, Y., Song, N., Yao, H. P., Jiang, S., Wang, Y., Zheng, Y., Zhou, Y., Ding, J., Hu, G., & Lu, M. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02597-6 · Cited by 61
The Role of Inflammasome NLPR3 in the Development and Therapy of Periodontitis
Zhao, Y., Quan, Y., Lei, T., Fan, L., Ge, X., & Hu, S. C. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.74575 · Cited by 59
Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
Yu, X., Zhao, Q., Zhang, X., Zhang, H., Liu, Y., Wu, X., Li, M., Li, X., Zhang, J., Ruan, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18619 · Cited by 60

Authors: Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R.
Affiliations: University of Science and Technology of China (CN)
Beijing Proteome Research Center (CN)
Corresponding author: Tian, Zhigang
Zhou, Rongbin
ORCID: Yan, Yiqing
Jiang, Wei
Liu, Lei
Wang, Xiaqiong
Ding, Chen
Tian, Zhigang
Zhou, Rongbin
Venue: Cell
Publisher: Elsevier BV
Published: 2015-01
Volume: 160
Issue: 1-2
Pages: 62-73
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2014.11.047
OpenAlex: W2084158898
Cited by: 1,014
References: 49
Citations by year: 2026: 59 · 2025: 93 · 2024: 98 · 2023: 103 · 2022: 108 · 2021: 124 · 2020: 112 · 2019: 79 · 2018: 104 · 2017: 66 · 2016: 47 · 2015: 20
FWCI: 34.32
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 379 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81222040, 81330078)
Ministry of Education of the People's Republic of China (20123402110010, 20123402120001)
National Key Research and Development Program of China (2013CB944904, 2014CB910800)
Fundamental Research Funds for the Central Universities
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: dopamine, NLRP3 inflammasome, dopamine D1 receptor, cAMP signaling, ubiquitination, inflammasome regulation, systemic inflammation, neuroinflammation, lipopolysaccharide-induced inflammation, peritonitis
MeSH terms: NLR Family, Pyrin Domain-Containing 3 Protein, Cyclic AMP, Animals, Autophagy, Carrier Proteins, Dopamine, Inflammation, Mice, Inbred C57BL, Receptors, Dopamine, Signal Transduction, Receptors, Dopamine D1, Neurotransmitter Agents, Mice, Ubiquitination, Inflammasomes, Protein Aggregates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks